D. Christensen

T. Rades, C. Foged, D. Christensen, 2019, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

A Liposome-Based Mycobacterial Vaccine Induces Potent Adult and Neonatal Multifunctional T Cells through the Exquisite Targeting of Dendritic Cells

P. Andersen, P. Lambert, E. Agger, 2009, PloS one.

Nano-Self-Assemblies Based on Synthetic Analogues of Mycobacterial Monomycoloyl Glycerol and DDA: Supramolecular Structure and Adjuvant Efficacy.

C. Foged, Carla B. Roces, D. Christensen, 2016, Molecular pharmaceutics.

alpha,alpha'-trehalose 6,6'-dibehenate in non-phospholipid-based liposomes enables direct interaction with trehalose, offering stability during freeze-drying.

H. M. Nielsen, C. Foged, Y. Perrie, 2008, Biochimica et biophysica acta.

Pustulan Activates Chicken Bone Marrow-Derived Dendritic Cells In Vitro and Promotes Ex Vivo CD4+ T Cell Recall Response to Infectious Bronchitis Virus

B. Guldbrandtsen, D. Christensen, J. Pitcovski, 2020, Vaccines.

Immunity by formulation design: induction of high CD8+ T-cell responses by poly(I:C) incorporated into the CAF01 adjuvant via a double emulsion method.

H. M. Nielsen, C. Foged, E. Agger, 2011, Journal of controlled release : official journal of the Controlled Release Society.

A novel Pan-viral prophylaxis strategy using vaccine adjuvant CAF09b protects against influenza virus infection

R. Trebbien, R. Cox, D. Christensen, 2021, bioRxiv.

CAF01 liposomes as a mucosal vaccine adjuvant: In vitro and in vivo investigations.

H. M. Nielsen, C. Foged, E. Agger, 2010, International journal of pharmaceutics.

Trehalose preserves DDA/TDB liposomes and their adjuvant effect during freeze-drying.

H. M. Nielsen, C. Foged, E. Agger, 2007, Biochimica et biophysica acta.

Applying Microfluidics for the Production of the Cationic Liposome-Based Vaccine Adjuvant CAF09b

Y. Perrie, D. Christensen, S. Schmidt, 2020, Pharmaceutics.

Liposomal vaccine delivery systems

Y. Perrie, D. Christensen, K. Korsholm, 2011, Expert opinion on drug delivery.

Liposomal cationic charge and antigen adsorption are important properties for the efficient deposition of antigen at the injection site and ability of the vaccine to induce a CMI response.

Yvonne Perrie, Dennis Christensen, Vincent W Bramwell, 2010, Journal of controlled release : official journal of the Controlled Release Society.

Adsorption of protein antigen to the cationic liposome adjuvant CAF®01 is required for induction of Th1 and Th17 responses but not for antibody induction

C. Foged, D. Christensen, I. Rosenkrands, 2021, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Systematic Investigation of the Role of Surfactant Composition and Choice of oil: Design of a Nanoemulsion-Based Adjuvant Inducing Concomitant Humoral and CD4+ T-Cell Responses

T. Rades, C. Foged, D. Christensen, 2017, Pharmaceutical Research.

Adjuvants Based on Synthetic Mycobacterial Cord Factor Analogues: Biophysical Properties of Neat Glycolipids and Nanoself-Assemblies with DDA.

C. Foged, D. Christensen, K. Korsholm, 2017, Molecular pharmaceutics.

Trehalose diester glycolipids are superior to the monoesters in binding to Mincle, activation of macrophages in vitro and adjuvant activity in vivo

C. Foged, D. Christensen, K. Korsholm, 2016, Innate immunity.

Th1 immune responses can be modulated by varying dimethyldioctadecylammonium and distearoyl‐sn‐glycero‐3‐phosphocholine content in liposomal adjuvants

Y. Perrie, Alexander J. K. Wilkinson, Vincent W. Bramwell, 2013, The Journal of pharmacy and pharmacology.

The physical stability of the recombinant tuberculosis fusion antigens h1 and h56.

C. R. Middaugh, L. Jorgensen, C. Foged, 2013, Journal of pharmaceutical sciences.

Designing CAF-adjuvanted dry powder vaccines: spray drying preserves the adjuvant activity of CAF01.

H. M. Nielsen, J. Rantanen, N. Larsen, 2013, Journal of controlled release : official journal of the Controlled Release Society.

Characterization of cationic liposomes based on dimethyldioctadecylammonium and synthetic cord factor from M. tuberculosis (trehalose 6,6'-dibehenate)-a novel adjuvant inducing both strong CMI and antibody responses.

P. Andersen, Y. Perrie, Daniel J Kirby, 2005, Biochimica et biophysica acta.

Cationic liposomes as vaccine adjuvants

E. Agger, D. Christensen, K. Korsholm, 2007, Expert review of vaccines.

Liposome-based cationic adjuvant formulations (CAF): Past, present, and future

Y. Perrie, Daniel J Kirby, E. Agger, 2009, Journal of liposome research.

Liposomes in adjuvant systems for parenteral delivery of vaccines

A. Mohammed, Y. Perrie, Vincent W. Bramwell, 2009 .

Mucosal boosting of H56:CAF01 immunization promotes lung-localized T cells and an accelerated pulmonary response to Mycobacterium tuberculosis infection without enhancing vaccine protection

E. Agger, D. Christensen, P. Andersen, 2019, Mucosal Immunology.

Site-Specific DC Surface Signatures Influence CD4+ T Cell Co-stimulation and Lung-Homing

P. Lambert, D. Christensen, P. Andersen, 2019, Front. Immunol..

Translating the fabrication of protein-loaded poly(lactic-co-glycolic acid) nanoparticles from bench to scale-independent production using microfluidics

Y. Perrie, Carla B. Roces, D. Christensen, 2020, Drug Delivery and Translational Research.

Comparative Systems Analyses Reveal Molecular Signatures of Clinically tested Vaccine Adjuvants

Intawat Nookaew, Stefan H. E. Kaufmann, Yuan Zhang, 2016, Scientific Reports.

Monocytes Elicit a Neutrophil-Independent Th1/Th17 Response Upon Immunization With a Mincle-Dependent Glycolipid Adjuvant

M. Mack, P. Murray, D. Christensen, 2022, Frontiers in Immunology.

Cationic liposomes as vaccine adjuvants

P. Andersen, E. Agger, D. Christensen, 2007, Expert review of vaccines.

Toll like-receptor agonist Pam3Cys modulates the immunogenicity of liposomes containing the tuberculosis vaccine candidate H56

D. Christensen, S. Stenger, G. Pedersen, 2020, Medical Microbiology and Immunology.

Seasonal Influenza Split Vaccines Confer Partial Cross-Protection against Heterologous Influenza Virus in Ferrets When Combined with the CAF01 Adjuvant

J. Christensen, D. Christensen, K. Korsholm, 2018, Front. Immunol..

A Mutated Prostatic Acid Phosphatase (PAP) Peptide-Based Vaccine Induces PAP-Specific CD8+ T Cells with Ex Vivo Cytotoxic Capacities in HHDII/DR1 Transgenic Mice

D. Christensen, A. Pockley, S. McArdle, 2022, Cancers.

A single immunization with CAF08 provides newborns with Th1-mediated protection against Respiratory Syncytial Virus infection

H. Steen, O. Levy, B. Graham, 2021, The Journal of Immunology.

Adjuvanted SARS-CoV-2 spike protein elicits neutralizing antibodies and CD4 T cell responses after a single immunization in mice

G. B. Karlsson Hedestam, D. Sheward, B. Murrell, 2020, EBioMedicine.

Parenteral Vaccination With a Tuberculosis Subunit Vaccine in Presence of Retinoic Acid Provides Early but Transient Protection to M. Tuberculosis Infection

D. Christensen, P. Andersen, C. Palma, 2019, Front. Immunol..

A Liposome-Based Adjuvant Containing Two Delivery Systems with the Ability to Induce Mucosal Immunoglobulin A Following a Parenteral Immunization.

J. Christensen, W. Jiskoot, P. Andersen, 2019, ACS nano.

Induction of CD8+ T-cell responses against subunit antigens by the novel cationic liposomal CAF09 adjuvant.

P. Andersen, D. Christensen, K. Korsholm, 2014, Vaccine.

CAF08 adjuvant enables single dose protection against respiratory syncytial virus infection in murine newborns

H. Steen, O. Levy, B. Graham, 2022, Nature Communications.

Induction of Th1/Th17 Responses and Antigen Exposure Is Required for the Synchronization of Dendritic Cell Activation

P. Lambert, E. Agger, D. Christensen, 2012 .

Maternal Antibodies Inhibit Neonatal and Infant Responses to Vaccination by Shaping the Early-Life B Cell Repertoire within Germinal Centers.

P. Lambert, D. Christensen, P. Andersen, 2019, Cell reports.

Intrapulmonary (i.pulmon.) Pull Immunization With the Tuberculosis Subunit Vaccine Candidate H56/CAF01 After Intramuscular (i.m.) Priming Elicits a Distinct Innate Myeloid Response and Activation of Antigen-Presenting Cells Than i.m. or i.pulmon. Prime Immunization Alone

P. Andersen, C. Foged, D. Christensen, 2020, Frontiers in Immunology.

IL-4 and helminth infection downregulate MINCLE-dependent macrophage response to mycobacteria and Th17 adjuvanticity

S. Wirtz, D. Christensen, C. Schubart, 2021, bioRxiv.

Protection against SARS-CoV-2 transmission by a parenteral prime—Intranasal boost vaccine strategy

J. Bukh, D. Sheward, B. Murrell, 2022, eBioMedicine.

Optimizing the design and dosing of dry powder inhaler formulations of the cationic liposome adjuvant CAF®01 for pulmonary immunization

C. Foged, D. Christensen, P. Andersen, 2022, Frontiers in Drug Delivery.

Cutting Edge: TNF Is Essential for Mycobacteria-Induced MINCLE Expression, Macrophage Activation, and Th17 Adjuvanticity

K. Pfeffer, P. Murray, D. Christensen, 2020, The Journal of Immunology.

Injection Vaccines Formulated with Nucleotide, Liposomal or Mineral Oil Adjuvants Induce Distinct Differences in Immunogenicity in Rainbow Trout

D. Christensen, A. Bojesen, K. R. Villumsen, 2020, Vaccines.

Local Th17/IgA immunity correlate with protection against intranasal infection with Streptococcus pyogenes

J. Christensen, P. Andersen, D. Christensen, 2017, PloS one.

Intranasal vaccination with killed Leishmania amazonensis promastigotes antigen (LaAg) associated with CAF01 adjuvant induces partial protection in BALB/c mice challenged with Leishmania (infantum) chagasi.

D. Christensen, L. P. Covre, D. C. O. Gomes, 2015, Parasitology.

A stable nanoparticulate DDA/MMG formulation acts synergistically with CpG ODN 1826 to enhance the CD4⁺ T-cell response.

C. Foged, D. Christensen, K. Korsholm, 2014, Nanomedicine.

Effect of incorporating cholesterol into DDA:TDB liposomal adjuvants on bilayer properties, biodistribution, and immune responses.

A. Devitt, Y. Perrie, Jitinder S. Wilkhu, 2014, Molecular pharmaceutics.

Increased Immunogenicity and Protective Efficacy of Influenza M2e Fused to a Tetramerizing Protein

B. Jensen, J. Christensen, K. Håkansson, 2012, PloS one.

Protection against Chlamydia Promoted by a Subunit Vaccine (CTH1) Compared with a Primary Intranasal Infection in a Mouse Genital Challenge Model

P. Andersen, M. Theisen, D. Christensen, 2010, PloS one.

Novel Generation Mycobacterial Adjuvant Based on Liposome-Encapsulated Monomycoloyl Glycerol from Mycobacterium bovis Bacillus Calmette-Guérin1

D. Minnikin, G. Besra, P. Andersen, 2009, The Journal of Immunology.

Bacillus Calmette-Guérin bovis Mycobacterium Monomycoloyl Glycerol from Based on Liposome-Encapsulated Novel Generation Mycobacterial Adjuvant

D. Minnikin, G. Besra, P. Andersen, 2009 .

Calmette-Guérin 1

D. Minnikin, G. Besra, P. Andersen, 2009 .

Comparison of the depot effect and immunogenicity of liposomes based on dimethyldioctadecylammonium (DDA), 3β-[N-(N',N'-Dimethylaminoethane)carbomyl] cholesterol (DC-Chol), and 1,2-Dioleoyl-3-trimethylammonium propane (DOTAP): prolonged liposome retention mediates stronger Th1 responses.

Y. Perrie, Vincent W. Bramwell, E. Agger, 2011, Molecular pharmaceutics.

Protein adsorption and displacement at lipid layers determined by total internal reflection fluorescence (TIRF)

L. Jorgensen, D. Christensen, I. Rosenkrands, 2009, Journal of liposome research.

Simultaneous quantification of multiple RNA cargoes co-loaded into nanoparticle-based delivery systems.

T. Rades, C. Foged, D. Christensen, 2022, International journal of pharmaceutics.

Increased humoral immunity by DNA vaccination using an α-tocopherol-based adjuvant

A. Fomsgaard, D. Christensen, J. Nielsen, 2017, Human vaccines & immunotherapeutics.

Investigating Prime-Pull Vaccination through a Combination of Parenteral Vaccination and Intranasal Boosting

Y. Perrie, Maryam T. Hussain, Carla B. Roces, 2019, Vaccines.

Vaccine Adjuvants Differentially Affect Kinetics of Antibody and Germinal Center Responses

D. Christensen, P. Andersen, G. Pedersen, 2020, Frontiers in Immunology.

Immune responses induced by nano‐self‐assembled lipid adjuvants based on a monomycoloyl glycerol analogue after vaccination with the Chlamydia trachomatis major outer membrane protein

T. Rades, H. Dietz, G. Winter, 2018, Journal of controlled release : official journal of the Controlled Release Society.

The supramolecular structure is decisive for the immunostimulatory properties of synthetic analogues of a mycobacterial lipid in vitro

C. Foged, E. Agger, D. Christensen, 2013 .

Hyaluronan is a natural and effective immunological adjuvant for protein-based vaccines

A. Rosato, V. Barbieri, D. Christensen, 2021, Cellular & Molecular Immunology.

Modulation of immune responses using adjuvants to facilitate therapeutic vaccination

C. Rosano, E. Lavelle, D. Christensen, 2020, Immunological reviews.

Sublingual Boosting with a Novel Mucoadhesive Thermogelling Hydrogel Following Parenteral CAF01 Priming as a Strategy Against Chlamydia trachomatis

D. Christensen, M. Landín, G. Pedersen, 2022, Advanced healthcare materials.

Elucidating the mechanisms of protein antigen adsorption to the CAF/NAF liposomal vaccine adjuvant systems: effect of charge, fluidity and antigen-to-lipid ratio.

L. Jorgensen, C. Foged, D. Christensen, 2014, Biochimica et biophysica acta.

Protein Antigen Adsorption to the DDA/TDB Liposomal Adjuvant: Effect on Protein Structure, Stability, and Liposome Physicochemical Characteristics

L. Jorgensen, C. Foged, D. Christensen, 2012, Pharmaceutical Research.

The Mincle-Activating Adjuvant TDB Induces MyD88-Dependent Th1 and Th17 Responses through IL-1R Signaling

S. Wirtz, E. Agger, D. Christensen, 2013, PloS one.

Immunological and physical evaluation of the multistage tuberculosis subunit vaccine candidate H56/CAF01 formulated as a spray-dried powder.

C. Foged, D. Christensen, P. Andersen, 2018, Vaccine.

A cationic vaccine adjuvant based on a saturated quaternary ammonium lipid have different in vivo distribution kinetics and display a distinct CD4 T cell-inducing capacity compared to its unsaturated analog.

Yvonne Perrie, Dennis Christensen, J. Christensen, 2012, Journal of controlled release : official journal of the Controlled Release Society.

SARS-CoV-2 spike HexaPro formulated in aluminium hydroxide and administered in an accelerated vaccination schedule partially protects Syrian Hamsters against viral challenge despite low neutralizing antibody responses

J. Bukh, D. Sheward, G. Mcinerney, 2023, Frontiers in Immunology.

A novel asexual blood-stage malaria vaccine candidate: PfRipr5 formulated with human-use adjuvants induces potent growth inhibitory antibodies

P. Alves, E. Takashima, T. Tsuboi, 2022, Frontiers in Immunology.

Comparison of vesicle based antigen delivery systems for delivery of hepatitis B surface antigen.

Yvonne Perrie, Dennis Christensen, Vincent W Bramwell, 2007, Journal of controlled release : official journal of the Controlled Release Society.

Alternatives to mineral oil adjuvants in vaccines against Aeromonas salmonicida subsp. salmonicida in rainbow trout offer reductions in adverse effects

D. Christensen, A. Bojesen, K. R. Villumsen, 2017, Scientific Reports.

A Novel Prophylaxis Strategy Using Liposomal Vaccine Adjuvant CAF09b Protects against Influenza Virus Disease

Fan Zhou, R. Trebbien, R. Cox, 2022, International journal of molecular sciences.

Rational Design and In Vivo Characterization of Vaccine Adjuvants.

D. Christensen, G. Pedersen, S. Schmidt, 2018, ILAR journal.

Oral vaccination using microdevices to deliver α-GalCer adjuvanted vaccine afford mucosal immunity.

A. Boisen, D. Christensen, L. Nielsen, 2022, Journal of controlled release : official journal of the Controlled Release Society.

Influenza NG-34 T cell conserved epitope adjuvanted with CAF01 as a possible influenza vaccine candidate

D. Christensen, A. Darji, L. Córdoba, 2020, Veterinary Research.

The Application of Liposomes as Vaccine Adjuvants

Y. Perrie, Alexander J. K. Wilkinson, E. Kastner, 2015 .

The in vivo expressed Mycobacterium tuberculosis (IVE-TB) antigen Rv2034 induces CD4⁺ T-cells that protect against pulmonary infection in HLA-DR transgenic mice and guinea pigs.

T. Ottenhoff, S. V. D. van den Eeden, L. Wilson, 2014, Vaccine.

Personalized therapy with peptide-based neoantigen vaccine (EVX-01) including a novel adjuvant, CAF®09b, in patients with metastatic melanoma

M. Donia, I. Svane, J. Kringelum, 2022, Oncoimmunology.

The administration route is decisive for the ability of the vaccine adjuvant CAF09 to induce antigen-specific CD8+ T-cell responses: The immunological consequences of the biodistribution profile

Thomas Rades, Yvonne Perrie, Dennis Christensen, 2016, Journal of controlled release : official journal of the Controlled Release Society.

CAF01 Potentiates Immune Responses and Efficacy of an Inactivated Influenza Vaccine in Ferrets

C. J. Martel, E. Agger, D. Christensen, 2011, PloS one.

Dual-Isotope SPECT/CT Imaging of the Tuberculosis Subunit Vaccine H56/CAF01: Induction of Strong Systemic and Mucosal IgA and T-Cell Responses in Mice Upon Subcutaneous Prime and Intrapulmonary Boost Immunization

U. Häfeli, C. Foged, D. Christensen, 2018, Front. Immunol..

Lipid conjugation of TLR7 agonist Resiquimod ensures co‐delivery with the liposomal Cationic Adjuvant Formulation 01 (CAF01) but does not enhance immunopotentiation compared to non‐conjugated Resiquimod+CAF01

Yvonne Perrie, Dennis Christensen, Y. Perrie, 2018, Journal of controlled release : official journal of the Controlled Release Society.

Liposomes based on dimethyldioctadecylammonium promote a depot effect and enhance immunogenicity of soluble antigen.

Yvonne Perrie, Dennis Christensen, Vincent W Bramwell, 2010, Journal of controlled release : official journal of the Controlled Release Society.

Scale-independent microfluidic production of cationic liposomal adjuvants and development of enhanced lymphatic targeting strategies.

Yvonne Perrie, Dennis Christensen, Y. Perrie, 2019, Molecular pharmaceutics.

Influence of trehalose 6,6'-diester (TDX) chain length on the physicochemical and immunopotentiating properties of DDA/TDX liposomes.

C. Foged, D. Christensen, K. Korsholm, 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Microscopy imaging of liposomes: from coverslips to environmental SEM.

Yvonne Perrie, Dennis Christensen, Afzal R Mohammed, 2011, International journal of pharmaceutics.

Robust antibody and CD8+ T-cell responses induced by P. falciparum CSP adsorbed to cationic liposomal adjuvant CAF09 confer sterilizing immunity against experimental rodent malaria infection

D. Christensen, F. Zavala, P. Andersen, 2017, npj Vaccines.

Robust antibody and CD8+ T-cell responses induced by P. falciparum CSP adsorbed to cationic liposomal adjuvant CAF09 confer sterilizing immunity against experimental rodent malaria infection

D. Christensen, F. Zavala, P. Andersen, 2017, npj Vaccines.

Overcoming the Neonatal Limitations of Inducing Germinal Centers through Liposome-Based Adjuvants Including C-Type Lectin Agonists Trehalose Dibehenate or Curdlan

R. Coler, E. Mohr, P. Lambert, 2018, Front. Immunol..

Pulmonary Administration of the Liposome-Based Adjuvant CAF01: Effect of Surface Charge on Mucosal Adjuvant Function.

P. Andersen, C. Foged, D. Christensen, 2022, Molecular pharmaceutics.

Synchronization of Dendritic Cell Activation and Antigen Exposure Is Required for the Induction of Th1/Th17 Responses

P. Lambert, E. Agger, D. Christensen, 2012, The Journal of Immunology.

Testing the H56 Vaccine Delivered in 4 Different Adjuvants as a BCG-Booster in a Non-Human Primate Model of Tuberculosis

B. V. Pedersen, P. Andersen, E. Agger, 2016, PloS one.

Vaccine adjuvants: Why and how

D. Christensen, 2016, Human vaccines & immunotherapeutics.

Systematic Investigation of the Role of Surfactant Composition and Choice of oil: Design of a Nanoemulsion-Based Adjuvant Inducing Concomitant Humoral and CD4+ T-Cell Responses

T. Rades, C. Foged, D. Christensen, 2017, Pharmaceutical Research.

Correlating liposomal adjuvant characteristics to in‐vivo cell‐mediated immunity using a novel Mycobacterium tuberculosis fusion protein: a multivariate analysis study

Y. Perrie, E. Kastner, Vincent W. Bramwell, 2015, The Journal of pharmacy and pharmacology.

Development and Evaluation of CAF01

D. Christensen, 2017 .

Induction of Cytotoxic T-Lymphocyte Responses Upon Subcutaneous Administration of a Subunit Vaccine Adjuvanted With an Emulsion Containing the Toll-Like Receptor 3 Ligand Poly(I:C)

T. Rades, C. Foged, D. Christensen, 2018, Front. Immunol..

C-type lectin receptor agonists elicit functional IL21-expressing Tfh cells and induce primary B cell responses in neonates

E. Mohr, P. Lambert, D. Christensen, 2023, Frontiers in Immunology.

A novel adjuvant formulation induces robust Th1/Th17 memory and mucosal recall responses in Non-Human Primates

D. Christensen, V. Contreras, R. LeGrand, 2023, bioRxiv.

High‐frequency vaccine‐induced CD8+ T cells specific for an epitope naturally processed during infection with Mycobacterium tuberculosis do not confer protection

P. Andersen, E. Agger, D. Christensen, 2014, European journal of immunology.

NIR transmission spectroscopy for rapid determination of lipid and lyoprotector content in liposomal vaccine adjuvant system CAF01.

H. M. Nielsen, J. Rantanen, M. Allesø, 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Cross-Protective Potential and Protection-Relevant Immune Mechanisms of Whole Inactivated Influenza Virus Vaccines Are Determined by Adjuvants and Route of Immunization

L. Boon, D. Christensen, Y. Bhide, 2019, Front. Immunol..

Immune responses following neonatal vaccination with conserved F4 fragment of VtaA proteins from virulent Glaesserella parasuis adjuvanted with CAF®01 or CDA

J. Segalés, F. Rodríguez, T. Ebensen, 2023, Vaccine: X.

Design of gadoteridol-loaded cationic liposomal adjuvant CAF01 for MRI of lung deposition of intrapulmonary administered particles.

F. Hyder, C. Foged, D. Christensen, 2019, Molecular pharmaceutics.

Method of manufacturing CAF®09 liposomes affect immune responses induced by adjuvanted subunit proteins.

C. Foged, D. Christensen, H. Franzyk, 2023, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Mucosal boosting of H56:CAF01 immunization promotes lung-localized T cells and an accelerated pulmonary response to Mycobacterium tuberculosis infection without enhancing vaccine protection

E. Agger, D. Christensen, P. Andersen, 2019, Mucosal Immunology.

CD4+ T Cells Induced by Tuberculosis Subunit Vaccine H1 Can Improve the HIV-1 Env Humoral Response by Intrastructural Help

K. Überla, D. Christensen, V. Temchura, 2020, Vaccines.

Translating the fabrication of protein-loaded poly(lactic-co-glycolic acid) nanoparticles from bench to scale-independent production using microfluidics

Y. Perrie, Carla B. Roces, D. Christensen, 2020, Drug Delivery and Translational Research.

Cationic liposomes as vaccine adjuvants

P. Andersen, E. Agger, D. Christensen, 2007, Expert review of vaccines.

Local Th17/IgA immunity correlate with protection against intranasal infection with Streptococcus pyogenes

J. Christensen, P. Andersen, D. Christensen, 2017, PloS one.

Peptide-specific T helper cells identified by MHC class II tetramers differentiate into several subtypes upon immunization with CAF01 adjuvanted H56 tuberculosis vaccine formulation.

P. Andersen, D. Christensen, Gennaro Prota, 2015, Vaccine.